Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARL | Q9H300 | 2/20 | 0.35 |
| ▸ | MGLL | Q99685 | 4/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17447 | 0.87 | MGLL (0.37) | PARLMGLLFAAH | |
| SCHEMBL2139612 | 0.83 | MGLL (0.35) | PARLMGLL | |
| Fluorene SCHEMBL23748026 | 0.80 | MAOA (0.42) | PARLMGLL | |
| Ethylene Glycol SCHEMBL8522385 | 0.79 | MGLL (0.33) | PARLMGLL | |
| SCHEMBL756450 | 0.79 | MGLL (0.36) | PARLMGLL | |
| SCHEMBL21228088 | 0.79 | MGLL (0.33) | PARLMGLL | |
| SCHEMBL20469204 | 0.79 | CCNE1 (0.38) | PARLMGLLFAAH | |
| SCHEMBL28388369 | 0.77 | PARL (0.33) | PARLMGLL | |
| SCHEMBL14063664 | 0.77 | MGLL (0.33) | MGLL | |
| SCHEMBL865136 | 0.77 | MGLL (0.40) | PARLMGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4025301-A1 | NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL DECLINE | The Regents of the University of California (US) | 2022-07-13 | — | — | EP | disclosed |
| WO-2021046339-A1 | NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL DECLINE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-03-11 | — | — | WO | disclosed |
| EP-1807118-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006110172-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS.INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| EP-0681572-B1 | THIAZOLIDINETHIONE-ACTIVATED POLYALKYLENE OXIDES | ENZON INC (US) | 2001-09-05 | — | — | EP | disclosed |
| EP-0681572-A1 | CYCLIC IMIDE THIONE ACTIVATED POLYALKYLENE OXIDES | ENZON, INC. (US) | 1995-11-15 | — | — | EP | disclosed |
| EP-0681572-A4 | CYCLIC IMIDE THIONE ACTIVATED POLYALKYLENE OXIDES. | ENZON INC (US) | 1995-09-22 | — | — | EP | disclosed |
| US-5405877-A | Cyclic imide thione activated polyalkylene oxides | ENZON, INC. (US) | 1995-04-11 | — | — | US | disclosed |
| US-5349001-A | Cyclic imide thione activated polyalkylene oxides | ENZON, INC. (US) | 1994-09-20 | — | — | US | disclosed |
| WO-1994017039-A1 | CYCLIC IMIDE THIONE ACTIVATED POLYALKYLENE OXIDES | ENZON, INC. (US) | 1994-08-04 | — | — | WO | disclosed |